Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism

Por Cariou, Bertrand, Zaïr, Yassine, Staels, Bart, Bruckert, Eric
Publicado em 2011

Disturbance of HDL apolipoprotein AI metabolism in severe hyperlipidemic and lipodystrophic HIV patients on a protease inhibitor treatment

Por Ouguerram, Khadija, Zair, Yassine, Billon, Stéphanie, krempf, Michel
Publicado em 2010

Effect of a high bicarbonate mineral water on fasting and postprandial lipemia in moderately hypercholesterolemic subjects: a pilot study

Por Zair, Yassine, Kasbi-Chadli, Fatima, Housez, Beatrice, Pichelin, Mathieu, Cazaubiel, Murielle, Raoux, François, Ouguerram, Khadija
Publicado em 2013

Multiplexed peptide analysis for kinetic measurements of major human apolipoproteins by LC/MS/MS

Por Croyal, Mikaël, Fall, Fanta, Ferchaud-Roucher, Véronique, Chétiveaux, Maud, Zaïr, Yassine, Ouguerram, Khadija, Krempf, Michel, Nobécourt, Estelle
Publicado no J Lipid Res (2016)

Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults

Por Cariou, Bertrand, Chetiveaux, Maud, Zaïr, Yassine, Pouteau, Etienne, Disse, Emmanuel, Guyomarc'h-Delasalle, Béatrice, Laville, Martine, Krempf, Michel
Publicado em 2011

Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects

Por Cariou, Bertrand, Hanf, Rémy, Lambert-Porcheron, Stéphanie, Zaïr, Yassine, Sauvinet, Valérie, Noël, Benoit, Flet, Laurent, Vidal, Hubert, Staels, Bart, Laville, Martine
Publicado em 2013

Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets

Por Cariou, Bertrand, Langhi, Cédric, Le Bras, Maëlle, Bortolotti, Murielle, Lê, Kim-Anne, Theytaz, Fanny, Le May, Cédric, Guyomarc’h-Delasalle, Béatrice, Zaïr, Yassine, Kreis, Roland, Boesch, Chris, Krempf, Michel, Tappy, Luc, Costet, Philippe
Publicado em 2013

A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1

Por Marques-Pinheiro, Alice, Marduel, Marie, Rabès, Jean-Pierre, Devillers, Martine, Villéger, Ludovic, Allard, Delphine, Weissenbach, Jean, Guerin, Maryse, Zair, Yassine, Erlich, Danièle, Junien, Claudine, Munnich, Arnold, Krempf, Michel, Abifadel, Marianne, Jaïs, Jean-Philippe, Boileau, Catherine, Varret, Mathilde
Publicado em 2010

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

Por Hopkins, Paul N., Defesche, Joep, Fouchier, Sigrid W., Bruckert, Eric, Luc, Gérald, Cariou, Bertrand, Sjouke, Barbara, Leren, Trond P., Harada-Shiba, Mariko, Mabuchi, Hiroshi, Rabès, Jean-Pierre, Carrié, Alain, van Heyningen, Charles, Carreau, Valérie, Farnier, Michel, Teoh, Yee P., Bourbon, Mafalda, Kawashiri, Masa-aki, Nohara, Atsushi, Soran, Handrean, Marais, A. David, Tada, Hayato, Abifadel, Marianne, Boileau, Catherine, Chanu, Bernard, Katsuda, Shoji, Kishimoto, Ichiro, Lambert, Gilles, Makino, Hisashi, Miyamoto, Yoshihiro, Pichelin, Matthieu, Yagi, Kunimasa, Yamagishi, Masakazu, Zair, Yassine, Mellis, Scott, Yancopoulos, George D., Stahl, Neil, Mendoza, Johanna, Du, Yunling, Hamon, Sara, Krempf, Michel, Swergold, Gary D.
Publicado no Circ Cardiovasc Genet (2015)